GEODE CAPITAL MANAGEMENT, LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$7,539,667
+59.6%
1,577,141
+41.9%
0.00%0.0%
Q2 2023$4,724,091
-16.8%
1,111,551
+3.9%
0.00%0.0%
Q1 2023$5,679,703
+87631.0%
1,069,624
+3.7%
0.00%0.0%
Q4 2022$6,474
-99.9%
1,030,987
+4.6%
0.00%
-50.0%
Q3 2022$10,395,000
+183.7%
985,370
+46.0%
0.00%
+100.0%
Q2 2022$3,664,000
-38.5%
674,773
+4.0%
0.00%0.0%
Q1 2022$5,955,000
+9.1%
648,757
+79.4%
0.00%0.0%
Q4 2021$5,457,000
-33.2%
361,632
+5.7%
0.00%0.0%
Q3 2021$8,168,000342,2150.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders